we differ not at all over the potential of prurisol- That is news to no one. It has a lot of appeal- if it works.
Your percentages are silly, as you know full well- what were the patient numbers for the ESTEEM trials?
if prurisol were the only drug for IP right now, would you invest a lot of money based on what you understand about P2a results? How confident are you those percentages you cite for P2a will hold up?